Login to Your Account



Washington Roundup

OIG: More Could Be Done to Reduce Medicare Drug Prices

By Mari Serebrov


Wednesday, August 17, 2011
WASHINGTON – Yes, Medicare Part D has produced larger than expected savings, but it might save even more if rebates on brand drugs and biologics were statutory, according to the Health and Human Services Office of Inspector General (OIG).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription